Learn more about Stimulant Use Disorder Treatment.
References
Farzam K, Faizy R, Saadabadi A. Stimulants. January 2023. https://www.ncbi.nlm.nih.gov/books/NBK539896/. Accessed September 20, 2023.
U.S. Department of Veterans Affairs. Stimulant Use Disorder. August 2023. https://www.mentalhealth.va.gov/substance-use/stimulants.asp#:~:text=Stimulant%20use%20disorder%20is%20the,such%20as%20Adderall%20and%20Ritalin.
Gupta M, Gokarakonda S, Attia F. Withdrawal Syndromes. January 2023. https://www.ncbi.nlm.nih.gov/books/NBK459239/. Accessed September 20, 2023.
Kampman K. Stimulant use disorders: Treatment overview. Saxon A, Friedman M, eds. July 2023. https://www.uptodate.com/contents/stimulant-use-disorders-treatment-overview.
Weinstock J, Wadeson HK, VanHeest JL. Exercise as an adjunct treatment for opiate agonist treatment: review of the current research and implementation strategies. Subst Abuse. 2012;33(4):350-360. doi:10.1080/08897077.2012.663327
Jahan A, Burgess D. Substance Use Disorder. January 2023. https://www.ncbi.nlm.nih.gov/books/NBK570642/. Accessed September 20, 2023.
Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(6):e208279. doi:10.1001/jamanetworkopen.2020.8279
SAMHSA. SAMHSA’s National Helpline. June 2023. https://www.samhsa.gov/find-help/national-helpline. Accessed September 20, 2023.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.